Sage Journals: Discover world-class research

Open access

Research article

First published 2017-4

A novel epidermal growth factor receptor inhibitor for treating lung cancer

Jiansheng Gao, Yuli Liang, Dongying Zhang [...]

Tumor Biology

Open access

Review article

First published 2017-5

Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

Shaohua Cui, Liyan Jiang

Tumor Biology

Free access

Research article

First published 2012-4

Therapeutic and Preventive Effects of an Epidermal Growth Factor Receptor Inhibitor on Oral Squamous Cell Carcinoma

H Ge, H Liu, Z Fu [...]

Journal of International Medical Research

Open access

Research article

First published 2023-11

An Analysis of Risk Factors for the Development of Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors

Rachel Bierbrier, Kathleen D’Aguanno, Sarah Oliel [...]

Journal of Cutaneous Medicine and Surgery

Retricted access

Research article

First published 2009-10

Evidence-Based Treatment Options for the Management of Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors

Eng Hooi Tan, Alexandre Chan

Annals of Pharmacotherapy

Retricted access

Research article

First published 2021-3

Development of a drug-eluting intraocular lens to deliver epidermal growth factor receptor inhibitor gefitinib for posterior capsule opacification prophylaxis

Stefan Kassumeh, Alexander Kueres, Anna Hillenmayer [...]

European Journal of Ophthalmology

Retricted access

Research article

First published 2025-10

Impact of pharmacist managed oral epidermal growth factor receptor inhibitors

Shirley Ng, Nicholas Baker, Fang Niu [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2016-11

Cutaneous Toxicity from Epidermal Growth Factor Receptor Inhibitors: Would a Subcutaneous Desensitization be Helpful? Case Report

Andrea D'Alessio, Sara Cecchini, Daniela Di Mauro [...]

Tumori Journal

Retricted access

Research article

First published 2003-12

Gefitinib (ZD1839,Iressa®): a selective epidermal growth factor receptor-tyrosine kinase inhibitor

Sachin R Shah, Tracey L Walsh, Casey B Williams [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2016-6

Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation–positive non-small cell lung cancers: an update for recent advances in therapeutics

Clement Chung

Journal of Oncology Pharmacy Practice

Search results